Navigation Links
Important funding for nanomedicine research to improve diagnosis and treatment
Date:3/16/2011

This release is available in French.

Toronto (March 16, 2011) Seven new research projects on regenerative medicine and nanomedicine received $16 million in funding. The studies, co-funded by the Canadian Institutes of Health Research (CIHR) and the Canadian Space Agency (CSA), were announced today at the University of Toronto by Dr. Colin Carrie, Member of Parliament for Oshawa; Dr. Jane Aubin, Scientific Director of the Canadian Institutes of Health Research Institute of Musculoskeletal Health and Arthritis; Mr. Gilles Leclerc, Director General, Space Exploration at the Canadian Space Agency; and Professor Peter Lewis, Associate Vice President (Research) at the University of Toronto. "The Government of Canada is proud to support regenerative medicine and nanomedicine projects that will translate into improved health for Canadians," said Dr. Carrie. "The knowledge that emerges from these research projects could also have wide ranging social and economic benefits."

"CIHR is delighted to partner with the Canadian Space Agency to support research aimed at developing technologies and approaches to improve patient outcome," said Dr. Aubin. "The research projects announced today seek to offer new therapies and approaches to treat illnesses and diseases, and ultimately offer better quality of life for patients and their families."

Research on nanomedicine and regenerative medicine is designed to prevent disease and improve human health. Nanomedicine delivers medical technologies that detect or function at the molecular level to diagnose and treat disease, while regenerative medicine stimulates the renewal of bodily tissues and organs or restores function through natural and bioengineered means. Various innovations in these areas have helped combat vascular diseases, cancer, diabetes, multiple sclerosis and other chronic diseases. By promoting research in these areas, CIHR and CSA will be moving Canada to the forefront of modern medical research.

"By working together, CIHR and the CSA are supporting scientific research and innovations that have applications for health care on earth and in space and provide real benefits for Canadians," said Mr. Leclerc. "Our hope is that cutting-edge diagnostic tools will improve astronaut health in space and be adapted for the early detection and treatment of disease here on earth."

"We congratulate the talented researchers who are leading the projects and believe their work on integrating new technologies into health research holds the potential to dramatically change the way we diagnose and treat diseases," said Professor Lewis.

The projects underwent a rigorous and competitive peer review process and were selected according to international standards of scientific excellence.

This funding will enable researchers to potentially:

  • Identify microlesions in multiple sclerosis, using a new tool for quantifying the cause of the disease and how well a treatment is working, Dr. Daniel Ct, Universit Laval;
  • Create personalized nanomedicines that silence cancer-causing genes, Dr. Petier Cullis, University of British Columbia;
  • Develop microchip-based devices to analyze prostate cancer markers in blood, Dr. Shana Kelley, University of Toronto;
  • Generate transplantable, insulin-producing cells from stem cells for diabetes, Dr. Timothy Kieffer, University of British Columbia;
  • Develop innovative sensorimotor rehabilitation approaches for patients with spinal cord injuries or stroke, Dr. Serge Rossignol, Universit de Montral;
  • Study how novel therapeutic interventions can regenerate blood vessels, Dr. Michael Sefton, University of Toronto; and,
  • Develop nanotechnology-enabled image-guided methods of diagnosing and treating lung cancer and vascular diseases, Dr. Gang Zheng, University Health Network.


'/>"/>

Contact: Media Relations
mediarelations@cihr-irsc.gc.ca
Canadian Institutes of Health Research
Source:Eurekalert

Related medicine news :

1. Parents important for keeping adolescents off alcohol
2. Neuroscientists find overlooked brain area is an important locus of depression
3. Researchers find reduced levels of an important neurotransmitter in MS
4. Coma and general anesthesia demonstrate important similarities
5. Researchers discover important link between adrenal gland hormone and brain in hypertension
6. Increased attention to womens health research has yielded gains on some important conditions, but progress lags on others
7. Workers rate safety most important workplace issue in new Labor Day study
8. Street outreach workers an important tool for violence prevention and intervention
9. SIRT1 gene important for memory
10. Healthy Serotonin Levels Shown to Positively Affect many Important Functions of the Mind and Body.
11. Free Clinics Play Important Role for Uninsured in U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... Catalent Pharma ... drugs, biologics and consumer health products, today announced that it will be co-hosting ... in innovative excipients and drug delivery solutions to health industries worldwide. The one ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... who administered fillers that resulted in severe facial disfiguration. After four frightening years ... by doctors at UCLA Medical Center, who removed the substances in a partial ...
(Date:1/19/2017)... ... 2017 , ... Ultimate Medical Academy (UMA) is preparing to ... making a difference in the lives of the next generation of healthcare professionals. ... educational institution, has more than 30,000 alumni and employs more than 2,000 professionals. ...
(Date:1/19/2017)... ... January 19, 2017 , ... Tribble Insurance Agency, a family owned and ... is inaugurating a charity event to honor Chad Phillip Dermyer, a local police trooper ... Chad Phillip Dermyer and his fellow officers were conducting routine stops of suspects when ...
(Date:1/19/2017)... San Mateo, CA (PRWEB) , ... January 19, ... ... now being taken in the 2017 Spring Create Real Impact contest from Impact ... through March 17 at http://www.createrealimpact.com . , Educational grants totaling $15,000 ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 2017  Sensus Healthcare, Inc. (NASDAQ: ... the treatment of non-melanoma skin cancers and other ... therapy, today announced that it will report its ... on Thursday, February 2, 2017 after the market close. ... call with the investment community on Thursday, February 2, ...
(Date:1/19/2017)... 19, 2017   Science Exchange , the leading ... that the first five replication studies from the ... published in eLife today. Despite intense scrutiny around ... practical evaluation of reproducibility rates that may identify ... other assessments of reproducibility, the results of this ...
(Date:1/19/2017)... 2017 While various reports ... reducing the FDA,s regulatory strictness as a way ... drug industry, many of the leading biotech and ... and development of advanced drug treatments and therapies.  ... developments include:  Moleculin Biotech, Inc., (NASDAQ: ...
Breaking Medicine Technology: